Global sterilization leader Sotera Health combines Sterigenics, Nelson Labs and Nordion to offer end-to-end sterilization and testing capabilities across medical devices, pharma, tissue, and food industries, presenting a broad cross-market opportunity for bundled solutions.

Strategic expansions With 63 facilities across 13 countries and a recent leadership transition, there is potential to leverage regional expansion, capacity upgrades, and new service introductions to cross-sell to existing customers and win new accounts in high-growth geographies.

Innovation and tech The company leverages advanced testing and sterilization technologies and a diverse tech stack, highlighting opportunities to position data-driven quality assurance, compliance, and rapid turnaround capabilities as differentiators for prospects seeking reliable risk mitigation.

Industry credibility A long-standing track record dating back to the 1930s and 1940s across sterilization, gamma technologies, and lab testing supports messaging around safety, regulatory readiness, and trusted partnerships to win business from risk-averse healthcare customers.

Executive momentum Upcoming leadership changes with a new CEO and an expanded board presence signal strategic direction and potential for new corporate priorities, enabling targeted outreach around partnerships, capital projects, and long-term outsourcing deals.